Dostinex is manufactured by Pfizer, Inc.  Dostinex is the brand name for cabergoline. It belongs to dopamine receptor antagonists group of drugs. The prolactin hormone is released from pituitary gland. Dostinex reduces the amount of prolactin hormone in the blood.  It is often used for management of Parkinson’s disease symptoms. In December 1996, it was approved by the FDA to treat only hyperprolactinemia. Even then many doctors in the United States prescribe Dostinex to patients with Parkinson’s disease. The use of Dostinex in Parkinson’s patients has showed severe and even fatal heart valve damage.

One of the severe Dostinex side effects is that it could lead to heart valve damage. It increases the risk of heart valve disease causing difficulty in the heart’s functioning. Heart valve failure can cause backwards flow of blood. This backflow of blood is known as valve regurgitation. This forces heart to work additionally and could result in serious heart injury or death.

Many studies published in January 2007 have linked Dostinex and other cabergoline drugs with many risks if they are given for treatment of Parkinson’s disease.  One study in the UK showed that nearly 20% of those taking cabergoline suffered damage to the heart valve. This ratio is five to seven times higher than the rate of those who did not take the drug.  A similar study in Italy revealed that around 29% patients taking this drug suffered heart valve damage. The symptoms of heart valve problems may include shortness of breath, fatigue and heart palpitations.

The basis of Dostinex Lawsuit against Pfizer

The Dostinex lawsuit against Pfizer could be filed on the basis of manufacturing an unsafe drug. Pfizer manufactured Dostinex to treat Parkinson’s disease and was approved by European health authorities. Although the FDA did not approve Dostinex to treat Parkinson’s disease in U.S.

The Dostinex lawsuits could blame that Pfizer was well aware of the fact that doctors would prescribe Dostinex to Parkinson’s patients in the United States. It should have given warning against use of this drug for Parkinson’s to medical practitioners.

These Dostinex lawsuits could get support from different studies done world over, which link Dostinex use to severe heart valve damage. These studies include

  • An Italian study showing that 29% of patients using Dostinex developed moderate-to-severe heart valve damage
  • A German study showed that Dostinex users were five times more likely to develop heart valve damage than patients not taking Dostinex
  • A British study also related this drug to heart valve damage. It revealed that 19% of patients taking Dostinex developed heart valve damage. It was 5-7% higher than patients who did not take Dostinex.

Other basis of Dostinex lawsuits is that Pfizer failed to warn users about potential Dostinex side effects. Especially Parkinson’s patients suffered a lot due to this. The lawsuit complaints could allege that Pfizer may be aware of serious and even fatal side effects of Dostinex and it failed to provide sufficient warning to the public.

Another point against Pfizer is that, once the severe side effects of Dostinex was evident then Pfizer should have discontinued this drug from the market. But it did not do so and the drug is still in the market.

Who can file a Dostinex Lawsuit?

If you or any of your close ones has suffered injury due to use of Dostinex use, you can file Dostinex Lawsuit against Pfizer. You need to get an experienced and efficient attorney to file your case. It is better if he had prior experience of handling Dostinex lawsuits.

You can ask for medical bills and compensation for your pain and suffering, lost work and mental anguish.